Vaughn DJ - Search Results

1

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.

Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB. Wheeler HE, et al. Among authors: vaughn dj. Clin Cancer Res. 2017 Jul 1;23(13):3325-3333. doi: 10.1158/1078-0432.CCR-16-2809. Epub 2016 Dec 30. Clin Cancer Res. 2017. PMID: 28039263 Free PMC article.

2

Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

Hinton S, Catalano P, Einhorn LH, Loehrer PJ Sr, Kuzel T, Vaughn D, Wilding G. Hinton S, et al. J Clin Oncol. 2002 Apr 1;20(7):1859-63. doi: 10.1200/JCO.2002.07.158. J Clin Oncol. 2002. PMID: 11919245 Clinical Trial.

3

Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 days.

Sun W, Stevenson JP, Gallagher ML, Vaughn D, Hahn SM, Haller DG, Cohen M, Kopit J, Gallant G, O'Dwyer PJ. Sun W, et al. Clin Cancer Res. 2003 Nov 1;9(14):5221-7. Clin Cancer Res. 2003. PMID: 14614002 Clinical Trial.

4

Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis.

Lubiniecki GM, Berlin JA, Weinstein RB, Vaughn DJ. Lubiniecki GM, et al. Among authors: vaughn dj. Cancer. 2004 Dec 15;101(12):2755-9. doi: 10.1002/cncr.20673. Cancer. 2004. PMID: 15536625 Free article.

5

Phase I trial of combretastatin a-4 phosphate with carboplatin.

Bilenker JH, Flaherty KT, Rosen M, Davis L, Gallagher M, Stevenson JP, Sun W, Vaughn D, Giantonio B, Zimmer R, Schnall M, O'Dwyer PJ. Bilenker JH, et al. Clin Cancer Res. 2005 Feb 15;11(4):1527-33. doi: 10.1158/1078-0432.CCR-04-1434. Clin Cancer Res. 2005. PMID: 15746056 Clinical Trial.

6

The Y deletion gr/gr and susceptibility to testicular germ cell tumor.

Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Oosterhuis JW, Gillis AJ, Looijenga LH, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Rudd M, Huddart R, Crockford GP, Forman D, Oliver DT, Einhorn L, Weber BL, Kramer J, McMaster M, Greene MH, Pike M, Cortessis V, Chen C, Schwartz SM, Bishop DT, Easton DF, Stratton MR, Rapley EA. Nathanson KL, et al. Among authors: vaughn dj. Am J Hum Genet. 2005 Dec;77(6):1034-43. doi: 10.1086/498455. Epub 2005 Oct 24. Am J Hum Genet. 2005. PMID: 16380914 Free PMC article.

7

American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.

Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF; American Society of Clinical Oncology. Gilligan TD, et al. Among authors: vaughn dj. J Clin Oncol. 2010 Jul 10;28(20):3388-404. doi: 10.1200/JCO.2009.26.4481. Epub 2010 Jun 7. J Clin Oncol. 2010. PMID: 20530278

8

Complications associated with chemotherapy in testicular cancer management.

Fung C, Vaughn DJ. Fung C, et al. Among authors: vaughn dj. Nat Rev Urol. 2011 Apr;8(4):213-22. doi: 10.1038/nrurol.2011.26. Epub 2011 Mar 15. Nat Rev Urol. 2011. PMID: 21403662 Review.

9

Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).

Fung C, Vaughn DJ, Mitra N, Ciosek SL, Vardhanabhuti S, Nathanson KL, Kanetsky PA. Fung C, et al. Among authors: vaughn dj. Front Endocrinol (Lausanne). 2012 Dec 13;3:163. doi: 10.3389/fendo.2012.00163. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23248619 Free PMC article.

10

Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors.

Jain A, Brames MJ, Vaughn DJ, Einhorn LH. Jain A, et al. Among authors: vaughn dj. Am J Clin Oncol. 2014 Oct;37(5):450-3. doi: 10.1097/COC.0b013e31827de90d. Am J Clin Oncol. 2014. PMID: 23388561 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page